Neurology:偏头痛,偏头痛残疾,创伤和性别少数群体个体的歧视

2022-09-02 Naomi MedSci原创

近日,一项发表在Neurology上的研究发现,偏头痛在性和/或性别少数(SGM)成年人样本中很常见。既往创伤和歧视经历与偏头痛残疾增加有关。精神病合并症在这种关系中发挥重要作用。

近日,一项发表在Neurology上的研究试图描述,在性和/或性别少数(SGM)成年人样本中,偏头痛的频率和严重程度,并检查创伤、歧视和偏头痛相关残疾之间的关系。

研究人员在2018年8月至10月的“身份和平等差异的人口研究”中对 SGM 人群进行了横向研究研究。主要的暴露是任何创伤或歧视,不管归因。根据偏头痛残疾评估(MIDAS)问卷评分≥11,主要结果为中重度偏头痛残疾。研究人员还进行了描述性分析,将有偏头痛的受访者与没有偏头痛的受访者进行比较。多变量 Logit模型研究了创伤/歧视和偏头痛残疾之间的关系,首先控制了社会人口学和临床因素,然后控制了精神病合并症。

结果:

  • 在3325名受访者中,1126名(33.9%)通过 ID-偏头痛标准筛选出偏头痛阳性。大多数偏头痛患者自我报告中度(n = 768,68.2%)或严重(n = 253,22.5%)强度。
  • MIDAS 评分中位数为11(四分差[ IQR ]5-25)。大多数偏头痛患者(n = 1055,93.7%)报告有创伤或歧视史。
  • 在未经调整的分析中,暴露于创伤和歧视与较高的中重度残疾几率相关(OR 1.76,95% CI 1.34-2.32)。
  • 在调整了自我报告的焦虑、抑郁和创伤后心理压力紧张综合症的精神病合并症后,这种关联失去了统计学意义。

结论: 偏头痛在该SGM 成年人样本中很常见,以前的创伤和歧视经历与偏头痛残疾增加有关。该研究结果表明,精神病合并症在这种关系中发挥重要作用,确定了SGM 患者偏头痛残疾的一个潜在的可改变的危险因素。 。

文献来源:Rosendale N, Guterman EL, Obedin-Maliver J, et al. Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals [published online ahead of print, 2022 Jul 11]. Neurology. 2022;10.1212/WNL.0000000000200941. doi:10.1212/WNL.0000000000200941

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2023-01-18 xjy13
  2. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-10-12 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 ms9000001538267476

    讲的真好,很受益

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 屋顶瞄爱赏月

    签到学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 yangchou

    好文章,值得一读。

    0

相关资讯

JAHA:静脉血栓栓塞后肺动脉高压的发生率和危险因素

在这一项大型的真实世界的VTE人群中,3.5%的患者在最初的VTE事件发生后的2年内发生PH。随着年龄的增长,在发生静脉血栓栓塞事件时有其他合并症的女性中,风险较高。

JAHA:智能手机记录的步数与心血管危险因素变化的关联

在大型日本成年人中,智能手机多年记录的步数与心血管疾病风险因素的有益变化相关,在关联上男性和女性存在一些差异。

HAEMOPHILIA:直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素:一项全国住院患者样本研究

肝细胞癌(HCC)是慢性丙型肝炎病毒(HCV)感染的主要并发症。尽管DAAs广泛使用,HCV仍然是血友病人群HCC的主要危险因素。

吸烟、饮酒和肥胖,是癌症致死三大帮凶!全球癌症负担报告

报告指出,这些危险因素导致了全球450万例癌症死亡,占癌症死亡的44.4%。

我国近六成心血管病可预防!大数据揭示 12 类可改变危险因素:不健康饮食对女性影响更大,吸烟是男性死亡的首位归因危险因素

研究指出,中国心血管疾病新发和死亡人数中,大约六成与可改变的危险因素有关,其中代谢危险因素和教育程度低占到了近一半以上。

控制七大因素,可防六成房颤!高血压是重要的危险因素

高血压对房颤的影响更大,房颤可通过改善生活方式预防,保持健康的体重、戒烟、戒酒、积极进行身体活动等是预防房颤的重要途径。

拓展阅读

AAN 2024大会盛况回顾,带您领略神经病学新高度!

作为神经科医生,您一定对AAN 2024年大会充满期待。我们为您精心整理了大会内容解读,包括最新研究成果、临床实践经验和未来发展趋势等,让您足不出户就能领略到大会的精彩盛况!点击立即查看别错过!

AAN 2024:饱受疼痛困扰!全球偏头痛患者“病耻感”情况

关于偏头痛患者的病耻感,不同国家之间存在显著差异。在加拿大、法国、德国、日本、英国和美国中,病耻感SQM得分法国最低而英国最高。

偏头痛的视觉先兆等级量表(Visual Aura Rating Scale,VARS)

偏头痛的视觉先兆等级量表(Visual Aura Rating Scale,VARS)

为什么『偏头痛』会增加心血管疾病?

本文旨在探讨偏头痛与心血管疾病之间的潜在关联,并分析其可能的生物学机制。

干货 I 偏头痛筛查评估工具与热点解读汇总篇,收藏起来慢慢用!

偏头痛筛查评估工具、热点解读、研究进展汇总篇,收藏起来慢慢用!

专治“偏头痛”!这种口服疗法,使超50%人发作天数减少至少一半

一项研究(ELEVATE试验)结果显示,对于既往接受2~4类预防偏头痛的常规口服治疗无效、患有阵发性偏头痛的成人患者来说,atogepant 60 mg每天一次治疗有效且安全。

2023 NICE 技术鉴定指南:瑞美吉泮治疗偏头痛【TA919】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-10-18

2023 循证临床实践指南:偏头痛治疗性运动处方

国外神经内科相关专家小组(统称) · 2023-07-07

2023 NICE 技术鉴定指南:瑞美吉泮预防偏头痛[TA906]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-07-05

FDA 指南:偏头痛的开发用于预防性治疗的药物

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2023-06-01